• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用CoaguChek进行口服抗凝治疗的患者自我监测]

[Patient self-monitoring of oral anticoagulation with CoaguChek].

作者信息

Caliezi C, Waber M, Pfiffner D, Saner H, Lämmle B, Wuillemin W A

机构信息

Hämatologisches Zentrallabor, Inselspital, Universitätsspital Bern.

出版信息

Schweiz Med Wochenschr. 2000 Jun 17;130(24):916-23.

PMID:10909717
Abstract

We investigated the feasibility, quality and safety of patient self-control of oral anticoagulation. The patients were selected by their physicians on the basis of criteria such as compliance, skills and motivation. After theoretical and practical training they self-monitored and self-adjusted their anticoagulant dosage for 6 months by weekly self-measurement of their INR values using a capillary whole blood prothrombin time monitor (CoaguChek). Venous INR measurements once a month served as quality control. There were 51 study participants, who performed a median 5 INR measurements per month. 75.8% of all registered INR values were within the recommended individual INR target ranges. The coefficient of correlation between capillary (y) and venous (x) INR values was r = 0.87 (regression analysis y = 1.0 x -0.2). The concordance of capillary and venous INR values was 80% with respect to the individual INR target ranges. There were 5 minor bleeding episodes and no overt thromboembolic recurrences during the study period. In conclusion, the study demonstrated that patient self-control of oral anticoagulation is feasible and achieves a high percentage of INR values within the recommended target ranges. Therefore, self-control of oral anticoagulation can be offered to skilled and motivated patients as an alternative to physician-guided antiocogulation. However, specific training of these selected patients is necessary.

摘要

我们调查了患者自我控制口服抗凝治疗的可行性、质量和安全性。医生根据依从性、技能和积极性等标准挑选患者。经过理论和实践培训后,他们使用毛细管全血凝血酶原时间监测仪(CoaguChek)每周自行测量国际标准化比值(INR)值,自我监测并自行调整抗凝药物剂量,为期6个月。每月进行一次静脉INR测量作为质量控制。共有51名研究参与者,他们每月进行INR测量的中位数为5次。所有记录的INR值中有75.8%在推荐的个体INR目标范围内。毛细管(y)和静脉(x)INR值之间的相关系数r = 0.87(回归分析y = 1.0x - 0.2)。就个体INR目标范围而言,毛细管和静脉INR值的一致性为80%。在研究期间发生了5次轻微出血事件,没有明显的血栓栓塞复发。总之,该研究表明患者自我控制口服抗凝治疗是可行的,并且在推荐的目标范围内能达到较高比例的INR值。因此,对于有技能和积极性的患者,可以提供口服抗凝治疗的自我控制作为医生指导抗凝治疗的替代方案。然而,对这些选定的患者进行特定培训是必要 的。

相似文献

1
[Patient self-monitoring of oral anticoagulation with CoaguChek].[使用CoaguChek进行口服抗凝治疗的患者自我监测]
Schweiz Med Wochenschr. 2000 Jun 17;130(24):916-23.
2
Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.用于患者自我检测以控制口服抗凝治疗的全血凝血酶原时间-国际标准化比值即时检测监测仪的质量保证计划。
Thromb Res. 2004;113(1):35-40. doi: 10.1016/j.thromres.2004.01.009.
3
[Comparison of Quick/INR values of whole capillary blood (CoaguChek Plus) and venous citrate plasma in patients with and without oral anticoagulation].[口服抗凝和未口服抗凝患者全毛细血管血(CoaguChek Plus)与静脉枸橼酸盐血浆的快速/国际标准化比值比较]
Schweiz Med Wochenschr. 1998 Oct 31;128(44):1723-9.
4
Self-monitoring of oral anticoagulation therapy in children.儿童口服抗凝治疗的自我监测
Acta Haematol. 2009;122(1):58-63. doi: 10.1159/000243726. Epub 2009 Oct 7.
5
Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).患者自我调整口服抗凝剂剂量能力的评估:一项关于便携式凝血酶原时间监测仪(COAGUCHECK)家庭使用的多中心研究。
Haematologica. 2000 Aug;85(8):826-31.
6
INR comparison between the CoaguChek S and a standard laboratory method among patients with self-management of oral anticoagulation.口服抗凝剂自我管理患者中CoaguChek S与标准实验室方法的国际标准化比值(INR)比较
Thromb Res. 2007;119(4):489-95. doi: 10.1016/j.thromres.2006.04.003. Epub 2006 Jun 9.
7
Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring.患者自我检测是实验室国际标准化比值(INR)监测的一种可靠且可接受的替代方法。
Br J Haematol. 2005 Jan;128(2):242-7. doi: 10.1111/j.1365-2141.2004.05300.x.
8
A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation.一项前瞻性对照试验,比较每周自我检测和自我给药与稳定口服抗凝治疗患者的标准管理。
Thromb Haemost. 2000 May;83(5):661-5.
9
Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).儿童口服抗凝治疗的床旁监测。使用国际参考凝血活酶制剂(rTF/95)对CoaguChek XS系统与静脉血国际标准化比值(INR)及静脉血INR进行比较。
Thromb Haemost. 2009 Jul;102(1):159-65. doi: 10.1160/TH09-01-0056.
10
Results of the performance verification of the CoaguChek XS system.CoaguChek XS系统性能验证结果。
Thromb Res. 2008;123(2):381-9. doi: 10.1016/j.thromres.2008.04.021. Epub 2008 Jun 27.